Molecular Cancer Therapeutics

310.5k citations
5.7k papers · · active since 2016

Impact in

  • Oncology top 1%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Cancer-related Molecular Pathways 549
    • HER2/EGFR in Cancer Research 390
    • Cancer, Hypoxia, and Metabolism 331

Molecular Cancer Therapeutics

5.6k papers receiving 302.6k citations

Peers

Molecular Cancer Therapeutics
Comparison fields: 5 of 211
  • Oncology 95.4k
  • Cancer Research 49.4k
  • Molecular Biology 165.6k
  • Immunology 28.6k
  • Genetics 13.2k
Replace International Journal of Oncology with:
International Journal of Oncology Japan
Nature Reviews Drug Discovery United States
BMC Cancer China
Journal of Cellular Biochemistry United States
Oncology Reports China
Frontiers in Pharmacology China
Frontiers in Oncology China
Biomedicine & Pharmacotherapy China
Cell Death and Differentiation United States
Clinica Chimica Acta United States
Molecular Cancer Therapeutics relative to International Journal of Oncology Japan International Journal of Oncology's profile →
Citations per field
00.5×1.5×2.0×
International Journal of Oncology · 1×
Citations per year

Countries where authors publish in Molecular Cancer Therapeutics

Since Specialization
Citations

This map shows the geographic impact of research published in Molecular Cancer Therapeutics. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Molecular Cancer Therapeutics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molecular Cancer Therapeutics more than expected).

Fields of papers published in Molecular Cancer Therapeutics

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Molecular Cancer Therapeutics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Molecular Cancer Therapeutics.

About Molecular Cancer Therapeutics

The 5.7k papers published in Molecular Cancer Therapeutics in the last decades have received a total of 310.5k indexed citations . Papers published in Molecular Cancer Therapeutics usually cover Oncology (2.5k papers), Cancer Research (947 papers), Molecular Biology (3.6k papers), Genetics (341 papers) and Immunology (645 papers) specifically the topics of Cancer-related Molecular Pathways (549 papers), PI3K/AKT/mTOR signaling in cancer (424 papers), Monoclonal and Polyclonal Antibodies Research (400 papers), HER2/EGFR in Cancer Research (390 papers), Cell death mechanisms and regulation (378 papers), Cancer, Hypoxia, and Metabolism (331 papers), Cancer therapeutics and mechanisms (318 papers) and Ubiquitin and proteasome pathways (318 papers). The most active scholars publishing in Molecular Cancer Therapeutics are Razelle Kurzrock, Sandip Pravin Patel, Edith A. Perez, Daniel D. Von Hoff, Garth Powis, Frank A. Sinicrope, Yves G. Pommier, Takumi Kawabe, Shengbing Huang and Santosh K. Katiyar.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact